Showing results (1131-1140 of 2,182) with videos related to
Sort By:
Pageof 219
Journal of Biopharmaceutical Statistics|August 19, 2003
A likelihood-based, counterfactual approach to accounting for treatment failures in clinical trialsMichele L Shaffer, Vernon M ChinchilliJournal of Biopharmaceutical Statistics|August 19, 2003
Probability models and computational models for ANOVA in multicenter clinical trialsThomas PermuttJournal of Biopharmaceutical Statistics|August 19, 2003
Optimal and efficient crossover designs under different assumptions about the carryover effectsA S Hedayat, John StufkenJournal of Biopharmaceutical Statistics|August 19, 2003
Estimating and comparing correct-use failure probabilities in clinical studies of condom functionalityMark A Weaver, Douglas J Taylor, Rosalie C DominikJournal of Biopharmaceutical Statistics|May 6, 2003
Assessing response profiles from incomplete longitudinal clinical trial data under regulatory considerationsCraig H Mallinckrodt, S W Scott Clark, Raymond J Carroll, et al.Journal of Biopharmaceutical Statistics|May 6, 2003
Chi-square test for R x C contingency tables with clustered dataSin-Ho Jung, Seung-Ho Kang, Chul AhnJournal of Biopharmaceutical Statistics|May 6, 2003
Bivariate longitudinal model for the analysis of the evolution of HIV RNA and CD4 cell count in HIV infection taking into account left censoring of HIV RNA measuresRodolphe Thiébaut, Hélène Jacqmin-Gadda, Catherine Leport, et al.Journal of Biopharmaceutical Statistics|May 6, 2003
A longitudinal approach for constructing beta-expectation tolerance intervalsR JonssonJournal of Biopharmaceutical Statistics|January 1, 1992
The analysis of a multiple-dose, combination-drug clinical trial using response surface methodologyJ A Phillips, V Cairns, G G KochJournal of Biopharmaceutical Statistics|January 1, 1992
False alarm rates of statistical methods used in determining increased frequency of reports on adverse drug reactionY TsongPageof 219